CEO MESSAGE

Shaping the Future of Safe and Convenient Endoscopic Solutions


TeCure is a healthcare startup dedicated to advancing endoscopic treatment through cutting-edge precision laser technology. Our mission is to provide safer, more effective, and more convenient procedures for medical professionals, ultimately enhancing patient outcomes.


With the global rise in gastrointestinal and metabolic diseases—driven by aging populations and increasing obesity—TeCure delivers targeted solutions that address today’s most pressing healthcare challenges.


We are committed to continuous research and innovation, developing a range of endoscopic laser treatment products designed to reduce the burden on healthcare providers and enable more accurate, minimally invasive procedures.


Our goal is to bring these innovations into real-world clinical settings through global commercialization, contributing to a better quality of life for patients worldwide.


Looking ahead, TeCure will continue to grow as a global leader in advanced laser treatment solutions—powered by our proprietary technology, clinical validation, and international collaborations.


Thank you.

HISTORY

Precision Guides US. changing Lives Drives Us.

Setting a new standard in medicine with precision laser technology
Setting a new standard in medicine with precision laser technology
  • 2025
  • Received Breakthrough Device Designation (EndoCure)
  • Commercialized intelligent healthcare prototype system 
  • Launched clinical trial for EsoLight 
  • Completed FDA presubmission 
  • Completed development of obesity–diabetes device (EndoCure) 
Proving trust through clinical practice and certifications
Proving trust through clinical practice and certifications
  • 2024
  • Awarded Grand Prize at Startup Leap Package IR 
  •  Completed preclinical study: Obesity–Diabetes (EndoCure) 
  •  Acquired ISO 13485 certification 
  •  Approved for MFDS IDE: GERD clinical trial (EsoLight) 
  •  Selected for Deep-Tech TIPS (KRW 1.5B, 2024–2027) 
  •  Certified as New Excellent Technology (NET) 
Leading the leap toward global expansion with TECURE
Leading the leap toward global expansion with TECURE
  • 2023
  •  Grand Prize at Welcome to TIPS IR (KOSME) 
  •  Completed usability evaluation of EsoLight (Samsung Medical Center) 
  •  Completed preclinical study: GERD (EsoLight) 
  •  Completed certified performance testing of EsoLight (KTL) 
Medical innovation for the future of patients
Medical innovation for the future of patients
  • 2022
  •  Certified for Medical Device GMP: Surgical Instruments 
  •  Established corporate R&D center 
  •  Certified for Medical Device GMP: Syringes and Needles 
  • 2021
  •  Obtained license for medical device manufacturing 
  • 2020
  •  Certified as a Venture Company 
  •  Approved for KRW 2B technology guarantee (U‑Tech Valley, KIBO) 
  •  Established TeCure with initial capital of KRW 20M 

CEO MESSAGE

Shaping the Future of Safe and Convenient Endoscopic Solutions

TeCure is a healthcare startup dedicated to advancing endoscopic treatment through cutting-edge precision laser technology. Our mission is to provide safer, more effective, and more convenient procedures for medical professionals, ultimately enhancing patient outcomes.


With the global rise in gastrointestinal and metabolic diseases—driven by aging populations and increasing obesity—TeCure delivers targeted solutions that address today’s most pressing healthcare challenges.


We are committed to continuous research and innovation, developing a range of endoscopic laser treatment products designed to reduce the burden on healthcare providers and enable more accurate, minimally invasive procedures.


Our goal is to bring these innovations into real-world clinical settings through global commercialization, contributing to a better quality of life for patients worldwide.


Looking ahead, TeCure will continue to grow as a global leader in advanced laser treatment solutions—powered by our proprietary technology, clinical validation, and international collaborations.


Thank you. 

HISTORY

Precision Guides Us. Changing Lives Drives Us.

Setting a new standard in medicine with precision laser technology
Setting a new standard in medicine with precision laser technology
Proving trust through clinical practice and certifications
Proving trust through clinical practice and certifications
Leading the leap toward global expansion with TECURE
Leading the leap toward global expansion with TECURE
Medical innovation for the future of patients
Medical innovation for the future of patients
  • 2025
  • • Received Breakthrough Device Designation (EndoCure) 
  • • Commercialized intelligent healthcare prototype system 
  • • Launched clinical trial for EsoLight 
  •  Completed FDA presubmission 
  •  Completed development of obesity–diabetes device (EndoCure) 
  • 2024
  • • Awarded Grand Prize at Startup Leap Package IR 
  •  Completed preclinical study: Obesity–Diabetes (EndoCure) 
  •  Acquired ISO 13485 certification 
  •  Approved for MFDS IDE: GERD clinical trial (EsoLight) 
  •  Selected for Deep-Tech TIPS (KRW 1.5B, 2024–2027) 
  •  Certified as New Excellent Technology (NET) 
  • 2023
  • • Grand Prize at Welcome to TIPS IR (KOSME) 
  •  Completed usability evaluation of EsoLight (Samsung Medical Center) 
  •  Completed preclinical study: GERD (EsoLight) 
  •  Completed certified performance testing of EsoLight (KTL) 
  • 2022
  • • Certified for Medical Device GMP: Surgical Instruments 
  • • Established corporate R&D center 
  • • Certified for Medical Device GMP: Syringes and Needles 
  • 2021
  • • Obtained license for medical device manufacturing 
  • 2020
  • • Certified as a Venture Company 
  • • Approved for KRW 2B technology guarantee (U‑Tech Valley, KIBO) 
  • • Established TeCure with initial capital of KRW 20M 

VISION & MISSION

Enhancing Lives with Patient-Focused Medical Devices

VISION & MISSION 

Enhancing Lives with Patient-Focused Medical Devices

01

TeCure is redefining treatment through focused innovation.

Our laser technology reduces procedural burdens for clinicians,

while ensuring safer and more convenient care for patients.

02

TeCure pushes the boundaries of medicine through technology.

We create a more accurate and effective treatment environment through advanced endoscopic solutions.

03

TeCure drives medical innovation on the global stage.

Supported by ongoing clinical trials, we are expanding globally to help patients access better care. 

04

Tecure is committed to sustainable healthcare. 

We pursue less invasive, lower-burden, and longer-lasting treatments 

by developing medical solutions that benefit both people and the planet.

01  

TeCure is redefining treatment through focused innovation.

Our laser technology reduces procedural burdens for clinicians,

while ensuring safer and more convenient care for patients.


02 

TeCure pushes the boundaries of medicine through technology.

We create a more accurate and effective treatment environment through advanced endoscopic solutions.

03  

TeCure drives medical innovation on the global stage.

Supported by ongoing clinical trials, we are expanding globally to help patients access better care. 

04  

TeCure is committed to sustainable healthcare.  

We pursue less invasive, lower-burden, and longer-lasting treatments 

by developing medical solutions that benefit both people and the planet. 


Company Name TeCure, Inc
CEO   Hyun Wook Kang 

Address   307 Hanmir Hall, 365 Sinseon-ro,

Nam-gu, Busan, Korea 
Tel  +82-51-629-5774  

Privacy Policy   I   Terms of Use   I   Careers

Copyright  © 2025  TeCure. All rights reserved 

 Company  TeCure, Inc CEO Hyun Wook Kang

 Address 307 Hanmir Hall, 365 Sinseon-ro, Nam-gu, Busan, Korea  Tel +82-51-629-5774  

 Privacy Policy     |     Terms of Use     |     Careers 

 Copyright © 2025 TeCure. All rights reserved. 

Brand Page
테스트1
테스트2
테스트3